Showing results (41-50 of 79) with videos related to
Sort By:
Pageof 8
Developmental Medicine and Child Neurology|August 4, 2004
Effectiveness of selective muscle-release surgery for children with cerebral palsy: longitudinal and stratified analysisIzumi Kondo, Kanoko Hosokawa, Manabu Iwata, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Overexpression of IL-15 in vivo increases antigen-driven memory CD8+ T cells following a microbe exposureToshiki Yajima, Hitoshi Nishimura, Ryotaro Ishimitsu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patientsTatsuya Kato, Nagato Sato, Atsushi Takano, et al.International Journal of Cancer|February 25, 2005
Soluble branched (1,4)-beta-D-glucans from Acetobacter species enhance antitumor activities against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell responseYoriyuki Kamiryo, Toshiki Yajima, Kimika Saito, et al.Journal of Virology|April 14, 2004
Intraepithelial gammadelta T cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type 2Hitoshi Nishimura, Toshiki Yajima, Yoshiko Kagimoto, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
Vdelta1+ gammadelta T cells producing CC chemokines may bridge a gap between neutrophils and macrophages in innate immunity during Escherichia coli infection in miceTetsuzo Tagawa, Hitoshi Nishimura, Toshiki Yajima, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2011
[Two cases of advanced colorectal cancer which demonstrated the reversibility of oxaliplatin-mediated increase in splenic volume]Shigeatsu Motoori, Takashi Kawase, Hitoshi Nishimura, et al.Cardiovascular Intervention and Therapeutics|July 7, 2017
Comparison of platelet aggregation response in switching regimen from prasugrel to clopidogrel between CYP2C19 extensive versus non-extensive metabolizersSoichiro Ebisawa, Yasushi Ueki, Tomoaki Mochidome, et al.Cancer Science|September 25, 2007
Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancerYuria Mano, Koji Takahashi, Nobuhisa Ishikawa, et al.Anticancer Research|January 30, 2003
Sarcomatoid adenocarcinoma of the lung: clinicopathological, immunohistochemical and molecular analysesKazunori Nishida, Yasuhito Kobayashi, Yuichi Ishikawa, et al.Pageof 8